Atlas Trials

Capecitabine and Oxaliplatin in Patients With Advanced or Metastatic Pancreatic Adenocarcinoma

Clinical trial NCT00585078 · COMPLETED

Trial details

NCT number
NCT00585078
Sponsor
Beth Israel Deaconess Medical Center
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Pancreatic Cancer
Start date
2004-05-01
Primary completion
2011-12-01
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.